Autor: |
Sellar RS; Department of Haematology, UCL Cancer Institute, University College London, London, United Kingdom.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA., Sperling AS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.; Division of Hematology, Brigham and Women's Hospital, Boston, Massachusetts, USA., Słabicki M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA., Gasser JA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA., McConkey ME; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA., Donovan KA; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts, USA., Mageed N; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts, USA., Adams DN; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Zou C; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Miller PG; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA., Dutta RK; Division of Hematology, Brigham and Women's Hospital, Boston, Massachusetts, USA., Boettcher S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medical Oncology and Hematology, University Hospital Zurich and University of Zurich, Zurich, Switzerland., Lin AE; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.; Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA., Sandoval B; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Quevedo Barrios VA; Division of Hematology, Brigham and Women's Hospital, Boston, Massachusetts, USA., Kovalcik V; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Koeppel J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA., Henderson EK; Department of Haematology, UCL Cancer Institute, University College London, London, United Kingdom., Fink EC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA., Yang L; Department of Systems Biology, City of Hope Comprehensive Cancer Center, Duarte, California, USA., Chan A; Department of Systems Biology, City of Hope Comprehensive Cancer Center, Duarte, California, USA., Pokharel SP; Department of Systems Biology, City of Hope Comprehensive Cancer Center, Duarte, California, USA., Bergstrom EJ; Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA., Burt R; Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA., Udeshi ND; Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA., Carr SA; Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA., Fischer ES; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts, USA., Chen CW; Department of Systems Biology, City of Hope Comprehensive Cancer Center, Duarte, California, USA., Ebert BL; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.; Howard Hughes Medical Institute, Boston, Massachusetts, USA. |